Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for mental fatigue and pain after traumatic brain injury or whiplash injury
2011-000925-60Phase 4Active
- Sponsor
- Kungälv Hospital
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of methylphenidate in traumatic brain injury (TBI) and Whiplash Associated Disorder (WAD), sponsored by Kungälv Hospital. Primary endpoint: Therapeutic effect on self-assessment outcomes. Started Feb 2011; status: active.
02
Drugs
methylphenidate
03
Conditions
traumatic brain injury (TBI)Whiplash Associated Disorder (WAD)
Beyond the preview
Go deeper on 2011-000925-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000925-60.